IMPACT OF AVERAGE WEEKLY DOSE OF RADIATION DURING RADIOTHERAPY ALONE OR CHEMORADIOTHERAPY IN HEAD AND NECK CANCER

被引：8
|
作者：
Dragovic, Aleksandar F. [4 ]
Bonner, James A. [4 ]
Spencer, Sharon A. [4 ]
Nabell, Lisle M. [1 ]
Carroll, William R. [2 ]
Caudell, Jimmy J. [3 ,4 ]
机构：
[1] Univ Alabama Birmingham, Dept Internal Med, Birmingham, AL USA
[2] Univ Alabama Birmingham, Dept Surg, Birmingham, AL 35294 USA
[3] Univ Mississippi, Dept Radiat Oncol, Med Ctr, Mississippi, AL USA
[4] Univ Alabama Birmingham, Dept Radiat Oncol, Birmingham, AL 35294 USA
来源：
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK | 2011年 / 33卷 / 11期
关键词：
head and neck cancer; radiotherapy; altered fractionation; chemotherapy; AWD; SQUAMOUS-CELL CARCINOMAS; LOCALLY ADVANCED HEAD; INTENSITY-MODULATED RADIOTHERAPY; ACCELERATED FRACTIONATION; LUNG-CARCINOMA; THERAPY; IRRADIATION; LARYNX; TRIAL;
D O I：
10.1002/hed.21634
中图分类号：
R76 [耳鼻咽喉科学];
学科分类号：
100213 ;
摘要：
Background. Altered fractionated radiotherapy (RT) has been shown to improve locoregional control (LRC) and overall survival (OS) in squamous cell cancer of the head and neck (SCCHN). We investigated patient outcomes using a new parameter: the average weekly dose (AWD). Methods. The medical records of 601 patients who received definitive RT for SCCHN were reviewed. AWD was calculated by dividing the total dose in Gray (Gy) by overall treatment time in weeks, and assessed for predictive value. Results. Various standard RT fractionation schedules were used. An AWD >10.0 Gy was associated with improved LRC at 2 years for patients treated with RT alone (80.9% vs 60.9%; p = .006), but not for those treated with concurrent chemoradiation (75.3% vs 77.3%; p = .77). Nonsignificant increases in late dysphagia were seen with AWD >10.0 Gy. Conclusion. An AWD of >10 Gy was found to be beneficial for RT alone regimens but not chemoradiotherapy regimens. (C) 2010 Wiley Periodicals, Inc. Head Neck 33: 1551-1556, 2011
引用
收藏
页码：1551 / 1556
页数：6
相关论文
共 50 条
  • [1] Risk factors for aspiration pneumonia during concurrent chemoradiotherapy or bio-radiotherapy for head and neck cancer
    Shirasu, Hiromichi
    Yokota, Tomoya
    Hamauchi, Satoshi
    Onozawa, Yusuke
    Ogawa, Hirofumi
    Onoe, Tsuyoshi
    Onitsuka, Tetsuro
    Yurikusa, Takashi
    Mori, Keita
    Yasui, Hirofumi
    BMC CANCER, 2020, 20 (01)
  • [2] A comparison of weekly versus 3-weekly cisplatin during adjuvant radiotherapy for high-risk head and neck cancer
    Oosting, Sjoukje F.
    Chen, Tom W. W.
    Huang, Shao H.
    Wang, Lisa
    Waldron, John
    Gilbert, Ralph
    Goldstein, David
    Halmos, Gyorgy B.
    Witjes, Max J. H.
    Gietema, Jourik A.
    O'Sullivan, Brian
    Langendijk, Johannes A.
    Siu, Lillian L.
    Hansen, Aaron R.
    ORAL ONCOLOGY, 2016, 59 : 43 - 49
  • [3] Chronic sinusitis in head and neck cancer patients who received radiotherapy or chemoradiotherapy
    Park, Young Min
    Cho, Jae-Gu
    Woo, Jeong-Soo
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2018, 275 (11) : 2805 - 2811
  • [4] Concomitant Weekly Cisplatin and Radiotherapy for Head and Neck Cancer
    Homma, Akihiro
    Inamura, Naoya
    Oridate, Nobuhiko
    Suzuki, Seigo
    Hatakeyama, Hiromitsu
    Mizumachi, Takatsugu
    Kano, Satoshi
    Sakashita, Tomohiro
    Onimaru, Rikiya
    Yasuda, Koichi
    Shirato, Hiroki
    Fukuda, Satoshi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (08) : 980 - 986
  • [5] Concurrent Chemoradiotherapy With Weekly Low-Dose Cisplatin for Japanese Patients With Head and Neck Squamous Cell Carcinoma
    Shinohara, Shogo
    Takebayashi, Shinji
    Hamaguchi, Kiyomi
    Michida, Tetsuhiko
    Tobe, Yota
    Ikenaga, Tadashi
    Yasumoto, Mami
    Hamamoto, Ayami
    Imagumbai, Toshiyuki
    Mitsuyoshi, Takamasa
    Ashida, Ryo
    Iwai, Takahiro
    Okabayashi, Shun
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2021, 15
  • [6] Gastrostomy vs nasogastric tube feeding in patients with head and neck cancer during radiotherapy alone or combined chemoradiotherapy
    Soria, Ainara
    Santacruz, Elisa
    Vega-Pinero, Belen
    Gion, Maria
    Molina, Javier
    Villamayor, Maria
    Mateo, Raquel
    Riveiro, Javier
    Nattero, Lia
    Botella-Carretero, Jose I.
    NUTRICION HOSPITALARIA, 2017, 34 (03) : 512 - 516
  • [7] Effect of HMB/Arg/Gln on the Prevention of Radiation Dermatitis in Head and Neck Cancer Patients Treated with Concurrent Chemoradiotherapy
    Imai, Takayuki
    Matsuura, Kazuto
    Asada, Yukinori
    Sagai, Shun
    Katagiri, Katsunori
    Ishida, Eiichi
    Saito, Daisuke
    Sadayasu, Rei
    Wada, Hitoshi
    Saijo, Shigeru
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2014, 44 (05) : 422 - 427
  • [8] Concurrent chemoradiotherapy with low-dose weekly platinum agent for head and neck carcinoma
    Kitano, Masayuki
    Kojima, Tsuyoshi
    Okanoue, Yusuke
    Fujimura, Shintaro
    Oyagi, Seiji
    Shoji, Kazuhiko
    Hori, Ryusuke
    CLINICAL OTOLARYNGOLOGY, 2020, 45 (06) : 952 - 955
  • [9] Age Alone Is Not a Barrier to Concurrent Chemoradiotherapy for Advanced Head and Neck Cancer
    Sexton, Gerard P.
    Walsh, Paul
    Moriarty, Frank
    O'Neill, James Paul
    ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 2023, 132 (03) : 275 - 283
  • [10] Impact of radiation dose distribution on nutritional supplementation needs in head and neck cancer radiotherapy: a voxel-based machine learning approach
    Madhavan, Sudharsan
    Gamez, Mauricio
    Garces, Yolanda I.
    Lester, Scott C.
    Ma, Daniel J.
    Mundy, Daniel W.
    Wittich, Michelle A. Neben
    Qian, Jing
    Routman, David M.
    Foote, Robert L.
    Shiraishi, Satomi
    FRONTIERS IN ONCOLOGY, 2024, 14
12345